Mesothelioma News and Research

RSS

Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.

Aspirin may inhibit the growth of mesothelioma, shows study

Aspirin may inhibit the growth of mesothelioma, an aggressive and deadly asbestos-related cancer, University of Hawai'i Cancer Center researchers have found.

7 Jul 2015

Mesothelioma.us adds in-depth resource guide to its website

Mesothelioma.us, a free online resource that is full of helpful resources for mesothelioma patients, has just added an in-depth resource guide to the site.

27 Jun 2015

Discovery sheds light on how the Hippo pathway maintains cellular balance

Researchers at University of California, San Diego School of Medicine have discovered a self-regulating loop in the Hippo pathway, a signaling channel garnering increased attention from cancer researchers due to its role in controlling organ size, cell proliferation and cell death.

27 Jun 2015

Understanding of tumor biology opens new opportunities to conduct clinical trial for thoracic tumors

Our understanding of tumor biology has improved and continues to expand at a rapid pace, and this has opened new opportunities for cancer clinical trials, particularly for thoracic tumors. The identification and molecular alterations in the cancer and the possibility to specifically and selectively target them, has dramatically improved the treatment efficacy in patients with lung cancer.

24 Jun 2015

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

Mesothelioma.us, an educational and authoritative website that offers free and in-depth resources for mesothelioma patients and their families, has just released a new case study that focuses on the experimental treatments for the disease.

15 Jun 2015

New article on occupations most likely to cause mesothelioma

Mesothelioma.us, a website that is devoted to offering people helpful resources and information about mesothelioma, has just posted a new article that takes a look at which occupations are most likely to cause mesothelioma. Titled "Asbestos Jobs Causing Mesothelioma," the article explains how working directly with asbestos is the most common way to develop the serious health condition, which attacks the lining of the lungs, stomach or heart.

2 Jun 2015

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

Eli Lilly and Company announced final results of the Phase III PROCLAIM trial that will also be discussed in an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

29 May 2015

New, authoritative website launched to educate people about mesothelioma

Mesothelioma.us is a new and authoritative website that is devoted to educating people about the rare form of cancer, mesothelioma. For people who have been diagnosed with mesothelioma and their friends and loved ones who wish to know more about the disease and its treatment options, the new website is one-stop mesothelioma information stop.

27 May 2015

CANCER-ID consortium aims to set up standard procedures for clinical validation of blood-based biomarkers

Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free DNA (cfDNA), circulating tumor DNA (ctDNA) and microRNAs (miRNAs) are potential indicators for the tumor burden of patients living with cancer.

30 Apr 2015

Pembrolizumab drug halts tumor growth in 76% of patients with pleural mesothelioma

The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.

20 Apr 2015

SELLAS inks exclusive global collaboration, license agreement with TrojanTec

SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.

15 Apr 2015

Physicians, researchers to discuss advances in cancer immunotherapies at UChicago symposium

The Ben May Department for Cancer Research at the University of Chicago will hold a day-long symposium on cancer immunotherapy for physicians and researchers.

18 Mar 2015

Mesothelioma Victims Center now offers guidance for former power plant workers with mesothelioma

The Mesothelioma Victims Center is now making the best possible compensation a reality for former power plant workers who have been diagnosed with mesothelioma, because these types of individuals could qualify for multi-million dollar mesothelioma settlements.

28 Feb 2015

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

According to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Acute Lymphoblastic Leukemia (ALL), the treatment approach to ALL is one of the most complex and intensive programs in cancer therapy.

24 Feb 2015

Mesothelioma Compensation Center educates individuals about mesothelioma compensation claim

The Mesothelioma Compensation Center is doing everything possible to educate all diagnosed victims of mesothelioma and their family members about the most critical component of a mesothelioma compensation claim that, believe it or not, comes down to the skill of the lawyer advancing the claim; especially if the diagnosed victim was exposed to asbestos in the automotive manufacturing or repair industry.

13 Feb 2015

Study finds higher levels of malignant mesothelioma cases in southern Nevada

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same region carcinogenic mineral fibers including actinolite asbestos, erionite, winchite, magnesioriebeckite and richterite were discovered.

11 Feb 2015

Diagnosed US Navy veterans, shipyard workers provided instant access to top mesothelioma compensation lawyers

The Mesothelioma Compensation Center is, once again, stepping up for diagnosed victims of mesothelioma exposed to asbestos while serving in the US Navy or at a shipyard, by making them a top priority when it comes to providing instant access to the nation's most skilled compensation attorneys because it is these individuals who deserve the best possible compensation.

9 Feb 2015

Discoveries suggest that asbestos may be more widespread in Nevada, Arizona

In 2011, geologists at the University of Nevada, Las Vegas, began discovering asbestos where none should be -- in granite rocks with a geologic history not previously known to produce asbestos.

2 Feb 2015

Mesothelioma Victims Center implores US homeowners to understand the potential hazards of asbestos

The Mesothelioma Victims Center is urging all US homeowners to familiarize themselves with the dangers of exposure to asbestos in any home constructed with the material as there could be a remote possibility of developing a malignant form of cancer called mesothelioma.